Physician profile
Thomas Diliberti
NPI 1205908589
$4,412.02
in general payments reported to CMS, 2019-2025
17 companies · $487 in 2025
The $487 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,818 · 2020: $95.72 · 2021: $48.37 · 2022: $1,345 · 2023: $332 · 2024: $286 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,105.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,467.42 | 2019-2024 | |
| Arthrex, INC. | $483.62 | 2019 | |
| Axogen | $423.34 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Integra Lifesciences Corporation | $223.34 | 2019-2022 | |
| Stryker Corporation | $162.64 | 2024-2025 | Conextions Tr Tendon Repair System-Implant Mechanism, Variax, Asnis |
| Medartis INC. | $151.85 | 2023 | Aptus |
| Smith+Nephew, INC. | $94.73 | 2023-2025 | Evos Mini, Vlp Mini-Mod, Safeguard |
| Orthofix Medical, INC. | $89.39 | 2022-2024 | Physio-Stim |
| Endo Pharmaceuticals INC. | $76.08 | 2019-2023 | Xiaflex |
| Extremity Medical | $48.37 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $46.42 | 2025 | |
| Bioventus LLC | $34.11 | 2025 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $31.60 | 2019 | |
| Acumed LLC | $29.68 | 2019 | |
| Endo USA, INC. | $20.79 | 2024 | Xiaflex |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $14.52 | 2025 | Exparel |
| Sonex Health, INC. | $14.12 | 2024 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Diliberti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.